2m 2m 2m 2m 2m 2m 2m
Charles Riv Lab (CRL)
NYSE
$291.62+$4.79 (+1.67%)
Price as of Oct 02, 2026 4:27 PM EDT- $13.7BMarket Cap
- 63.57%1-Year Change
- Diagnostics & ResearchIndustry
Charles Riv Lab (CRL)
$291.62+$4.79 (+1.67%)
CRL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $286.83 | ||
Change | -$8.18 (-2.77%) | ||
Open | $291.86 | ||
High | $297.00 | ||
Low | $284.61 | ||
Previous Close | $295.01 | ||
Volume | 823,070 | ||
30-Day Average Volume | 951,429 | ||
1-Week Change | -2.58% | ||
1-Month Change | 1.59% | ||
1-Year Change | 63.57% | ||
3-Year Change | 46.36% | ||
5-Year Change | -31.16% | ||
Fundamentals | |||
Shares Outstanding | 47.7M | ||
Total Assets | $7.5B | ||
Market Cap | $13.7B | ||
Enterprise Value | $16.1B | ||
Period: QTR TTM FY | |||
Revenue | $808.3M | ||
Net Income | -$1.5M | ||
Free Cash Flow | $148.6M | ||
EBIT | $52.4M | ||
EBITDA | $119.7M | ||
Net Working Capital | $394.4M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | 135 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 5 | ||
P/E | -9,561 | ||
PEG | -106 | ||
Price/Free Cash Flow | 92 | ||
Price/Operating Cash Flow | 76 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue